Synaptogenix Inc (SNPX) Stock
SNPX is no longer traded. Synaptogenix was delisted from the Nasdaq in August 2025.
Prices on this page are historical; the last trade was August 29, 2025 at $5.82.
Synaptogenix stock price history
SNPX final trading statistics
- Final close
- $5.82
- Final trading day
- Aug 29, 2025
- Market cap at delisting
- $8.09M
- Shares outstanding
- 1.39M
- Final 52-week range
- $1.84 – $11.98
- Avg. volume (final 3 mo.)
- 1,077,968
- All-time high (split-adj.)
- $343.00 · Oct 2021
- All-time low (split-adj.)
- $2.00 · Apr 2025
- Return since IPO
- -93.2%
- Beta
- 1.30
- Book value / share
- $3.72
- Price / book
- 1.56
Synaptogenix annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$12.8M | -$10.34 |
| FY2023 | $0.00 | -$6.0M | -$1.73 |
| FY2022 | $0.00 | -$5.5M | -$2.07 |
| FY2021 | $0.00 | -$12.6M | -$2.79 |
| FY2020 | $0.00 | -$14.2M | -$13.22 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Synaptogenix Inc
TAO Synergies Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. The company was incorporated in 2012 and is headquartered in New York, New York.n as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. The company was incorporated in 2012 and is headquartered in New York, New York.
Synaptogenix stock FAQ
What happened to Synaptogenix stock?
Synaptogenix stock was delisted from the Nasdaq. Its final close was $5.82 on August 29, 2025.
Is SNPX stock still trading?
No. SNPX was delisted from the Nasdaq in August 2025 and no longer trades on a U.S. exchange.
What was the last price of SNPX stock?
SNPX closed at $5.82 on its final trading day, August 29, 2025, for a market value of about $8.09M.
What were Synaptogenix's revenue and earnings in its last full fiscal year?
Synaptogenix reported revenue of $0.00 and net income of -$12.8M in fiscal 2024, its last full year as a public company.
When did Synaptogenix go public?
Synaptogenix Inc stock began trading on December 8, 2020.